Sign inJoin waitlistJoin the waitlist

Pierre Saintigny

Medical Oncology

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
2013–2015
Internal Medicine
2010–2013
Doctor of Medicine
2006–2010

Research

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor…
Clinical Cancer Research · 2013 · 876 citations
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1
Cancer Discovery · 2012 · 467 citations
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome
Journal of the National Cancer Institute · 2012 · 461 citations

John Heymach
13 papers
Scott Lippman
13 papers · 10 as a resident
EK
Edward Kim
12 papers
Adel El-Naggar
10 papers
WH
Waun Hong
10 papers
John Minna
8 papers
JL
Joanna Lee
6 papers · 5 as a resident
VP
Vassiliki Papadimitrakopoulou
6 papers
RH
Roy Herbst
5 papers
Ann Gillenwater
4 papers
Lauren Byers
4 papers
Razelle Kurzrock
4 papers

Clinical trials

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
Principal investigator · Unknown
Centre Leon Berard
2021–2025
A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC
Principal investigator · Terminated
Centre Leon Berard
2018–2020
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Study director · Recruiting
Centre Leon Berard
2015–2026